MLSS — Milestone Scientific Balance Sheet
0.000.00%
- $85.43m
- $82.24m
- $8.63m
- 52
- 10
- 83
- 46
Annual balance sheet for Milestone Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14.2 | 14.8 | 8.72 | 5.95 | 3.26 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.08 | 0.943 | 0.694 | 0.313 | 0.475 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 18.6 | 18.9 | 13 | 10.8 | 9.29 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.663 | 0.574 | 0.479 | 0.374 | 0.338 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 19.6 | 19.8 | 13.7 | 11.4 | 9.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.88 | 3.1 | 3.3 | 3.08 | 3.74 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.37 | 3.44 | 3.48 | 3.36 | 3.96 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 16.2 | 16.4 | 10.2 | 8.01 | 5.83 |
Total Liabilities & Shareholders' Equity | 19.6 | 19.8 | 13.7 | 11.4 | 9.8 |
Total Common Shares Outstanding |